Episode
EULAR 2026 Daily Podcast Day 4c
- Podcast
- Rheumnow Podcast
- Published
- Jun 8, 2026
- Duration seconds
- 1494
- Processing state
not_requested- Canonical source
- https://rheumnow.podbean.com/e/eular-2026-daily-podcast-day-4c/
Actions
POST https://stenobird.com/v1/public/podcasts/rheumnow-podcast-587987/episodes/eular-2026-daily-podcast-day-4c/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/rheumnow-podcast-587987/eular-2026-daily-podcast-day-4c.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Guselkumab Delivers Across the PsA Disease Spectrum: APEX TrialRA BRIDGE and RA BRANCH trials: Baricitinib and VTE RiskImproving Referrals for Inflammatory Arthritis"Combination Therapy: Off the Shelf Allogenic NK and Rituximab in Rheumatic Disease